ViATIM provides simultaneous active immunisation against hepatitis A and typhoid fever via an easy to use dual chamber syringe.
ViATIM Prescribing information
Being able to help protect your patients against hepatitis A and typhoid fever in a single injection is convenient for your patients who may require a number of other injections ahead of their travels.
ViATIM helps provide protection against both hepatitis A and typhoid fever. A single dose from a dual chamber syringe provides protection against these infectious diseases for up to 3 years by day 14.1
Seroprotection rates with ViATIM are consistent with those from monovalent vaccines administered separately.1
|
Presentation |
Schedule |
Further doses |
Age range |
|
1 ml prefilled dual-chamber syringe Available in 1 syringe packs |
1 dose |
In order to provide long-term protection against infection caused by the hepatitis A virus, a second dose (booster) of an inactivated hepatitis A vaccine should be given.
• In subjects who have
received one dose of
Viatim®: • In subjects who have received
one dose of monovalent hepatitis
A vaccine: In subjects who remain at risk of typhoid fever, revaccination against typhoid fever should be carried out with a single dose of a typhoid Vi polysaccharide vaccine every 3 years |
16 years+ |
References:
Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.
Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.
• Simply visit https://sanofi.medisa.com
• Select the user group which best describes your role in your organisation
• Narrow your search by selecting the appropriate disease area
• Select which materials you would like to receive and how many
• Log-in or register to create an account
• Confirm your order
Date of preparation: November 2018 | SAGB.MIS.18.08.1323x